Hci Viocare (VICA) 4.8000 $VICA
HCi Viocare Reveals Wearable Technology for Recreational Runners and Athletes
eTeligis - Wed Mar 11, 10:48AM CDT
ATHENS, Greece, via ETELIGIS INC., 03/09/2015 - - HCi Viocare (the "Company"
(OTCQB: VICA), is today unveiling the groundbreaking Smart Insole, a connected product that fits into a training shoe, enabling runners to improve their performance and avoid injury.
HCi Viocare Signs Lease on Premises in Glasgow for its First Viocare Center
ACCESSWIRE - Mon Mar 02, 8:50AM CST
ATHENS, GREECE / ACCESSWIRE / March 2, 2015 / HCi Viocare (the "Company" (OTCQB:VICA), today announced that the HCi Viocare group has entered into a lease agreement for a modern, stand-alone 5,300 square foot facility in Glasgow, Scotland with an entry date of 1 March, 2015.
HCi VioCare Launches New Website and Domain
ACCESSWIRE - Thu Feb 19, 8:45AM CST
ATHENS, GR / ACCESSWIRE / February 19, 2015 / HCi Viocare (OTCQB: VICA), (the "Company" today announced the launch of its new domain and website, with improved functionality, design, and navigation.
Bioengineering Experts HCi Viocare to Unveil Smart Diabetic Insole at ATTD Conference
ACCESSWIRE - Tue Feb 17, 8:03AM CST
ATHENS, GREECE / ACCESSWIRE / February 17, 2015 / HCi Viocare (the "Company" (OTCQB: VICA), today announced that they will be unveiling their smart diabetic insole at the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Paris on the 18th and 19th of February.
HCi Viocare Files Patent Application in Relation to Low-Cost, Portable Motion Capture and Gait Analysis Technology
ACCESSWIRE - Mon Feb 09, 6:38AM CST
ATHENS, GREECE / ACCESSWIRE / February 9, 2015 / HCi Viocare (the "Company" (OTCQB: VICA), is pleased to announce that it has filed a patent application in relation to pioneering low-cost, portable motion capture and gait analysis technology, which has applications in a range of sectors, including athletic wearable devices, physiotherapy, orthotics and potentially also gaming and film.
HCi Viocare Files Patent Application for its Ground-Breaking Shear Sensing Technology
ACCESSWIRE - Wed Feb 04, 9:56AM CST
ATHENS, GREECE / ACCESSWIRE / February 4, 2015 / HCi Viocare (the "Company" (OTCQB: VICA), is pleased to announce that it has filed a patent application for its ground-breaking shear sensing system technology, which supports the development of low cost, flexible and scalable sensor systems in a range of sectors including wearable devices, medical devices (e.g. diabetic foot), Prosthetics & Orthotics and automotive health and safety.
HCi Viocare Files Patent Application for its Innovative Pressure Sensing Technology
ACCESSWIRE - Mon Feb 02, 10:18AM CST
ATHENS, GREECE / ACCESSWIRE / February 2, 2015 / HCi Viocare (the "Company" (OTCQB: VICA), is pleased to announce that it has filed a patent application for its innovative pressure sensing system technology, which supports the development of very low cost, flexible and scalable pressure sensing devices in a range of sectors including wearable devices, Prosthetics & Orthotics, medical devices (e.g. for the diabetic foot), and automotive health and safety.
HCi Viocare Strengthens Management Team with New COO and Investor Relations Executive
ACCESSWIRE - Mon Jan 26, 1:19PM CST
ATHENS, GREECE / ACCESSWIRE / January 26, 2015 / HCi Viocare (OTCQB: VICA), (the "Company" announced today that it has strengthened its management team with the arrival of new COO Heleen Kist and Investor Relations executive Mikulas Dylowicz, who has been retained as a consultant. The appointments come at a time of operational growth for the company, which is setting up a chain of Prosthetic, Orthotic and Diabetic foot rehabilitation centres in Europe and progressing an R&D portfolio of devices for the wider health & wellbeing industry.
HCi VioCare Announces Collaboration Between UK-Based Subsidiary and University of Strathclyde
ACCESSWIRE - Tue Oct 07, 12:01PM CDT
GLASGOW, SCOTLAND / ACCESSWIRE / October 7, 2014 / HCi VioCare (OTCQB: VICA), is pleased to announce that its wholly owned UK subsidiary, HCi VioCare Technologies Limited ("HCi VioCare" has entered into an agreement with the Biomedical Engineering Department of the University of Strathclyde in Glasgow, one of the leading Bioengineering and Prosthetics and Orthotics (P&O) research institutes worldwide, to further the development of its innovative technologies through access to the University's laboratory space and machinery.
HCi Viocare Reveals Wearable Technology for Recreational Runners and Athletes
eTeligis - Wed Mar 11, 10:48AM CDT
ATHENS, Greece, via ETELIGIS INC., 03/09/2015 - - HCi Viocare (the "Company"
(OTCQB: VICA), is today unveiling the groundbreaking Smart Insole, a connected product that fits into a training shoe, enabling runners to improve their performance and avoid injury. HCi Viocare Signs Lease on Premises in Glasgow for its First Viocare Center
ACCESSWIRE - Mon Mar 02, 8:50AM CST
ATHENS, GREECE / ACCESSWIRE / March 2, 2015 / HCi Viocare (the "Company"
(OTCQB:VICA), today announced that the HCi Viocare group has entered into a lease agreement for a modern, stand-alone 5,300 square foot facility in Glasgow, Scotland with an entry date of 1 March, 2015. HCi VioCare Launches New Website and Domain
ACCESSWIRE - Thu Feb 19, 8:45AM CST
ATHENS, GR / ACCESSWIRE / February 19, 2015 / HCi Viocare (OTCQB: VICA), (the "Company"
today announced the launch of its new domain and website, with improved functionality, design, and navigation. Bioengineering Experts HCi Viocare to Unveil Smart Diabetic Insole at ATTD Conference
ACCESSWIRE - Tue Feb 17, 8:03AM CST
ATHENS, GREECE / ACCESSWIRE / February 17, 2015 / HCi Viocare (the "Company"
(OTCQB: VICA), today announced that they will be unveiling their smart diabetic insole at the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Paris on the 18th and 19th of February. HCi Viocare Files Patent Application in Relation to Low-Cost, Portable Motion Capture and Gait Analysis Technology
ACCESSWIRE - Mon Feb 09, 6:38AM CST
ATHENS, GREECE / ACCESSWIRE / February 9, 2015 / HCi Viocare (the "Company"
(OTCQB: VICA), is pleased to announce that it has filed a patent application in relation to pioneering low-cost, portable motion capture and gait analysis technology, which has applications in a range of sectors, including athletic wearable devices, physiotherapy, orthotics and potentially also gaming and film. HCi Viocare Files Patent Application for its Ground-Breaking Shear Sensing Technology
ACCESSWIRE - Wed Feb 04, 9:56AM CST
ATHENS, GREECE / ACCESSWIRE / February 4, 2015 / HCi Viocare (the "Company"
(OTCQB: VICA), is pleased to announce that it has filed a patent application for its ground-breaking shear sensing system technology, which supports the development of low cost, flexible and scalable sensor systems in a range of sectors including wearable devices, medical devices (e.g. diabetic foot), Prosthetics & Orthotics and automotive health and safety. HCi Viocare Files Patent Application for its Innovative Pressure Sensing Technology
ACCESSWIRE - Mon Feb 02, 10:18AM CST
ATHENS, GREECE / ACCESSWIRE / February 2, 2015 / HCi Viocare (the "Company"
(OTCQB: VICA), is pleased to announce that it has filed a patent application for its innovative pressure sensing system technology, which supports the development of very low cost, flexible and scalable pressure sensing devices in a range of sectors including wearable devices, Prosthetics & Orthotics, medical devices (e.g. for the diabetic foot), and automotive health and safety. HCi Viocare Strengthens Management Team with New COO and Investor Relations Executive
ACCESSWIRE - Mon Jan 26, 1:19PM CST
ATHENS, GREECE / ACCESSWIRE / January 26, 2015 / HCi Viocare (OTCQB: VICA), (the "Company"
announced today that it has strengthened its management team with the arrival of new COO Heleen Kist and Investor Relations executive Mikulas Dylowicz, who has been retained as a consultant. The appointments come at a time of operational growth for the company, which is setting up a chain of Prosthetic, Orthotic and Diabetic foot rehabilitation centres in Europe and progressing an R&D portfolio of devices for the wider health & wellbeing industry. HCi VioCare Announces Collaboration Between UK-Based Subsidiary and University of Strathclyde
ACCESSWIRE - Tue Oct 07, 12:01PM CDT
GLASGOW, SCOTLAND / ACCESSWIRE / October 7, 2014 / HCi VioCare (OTCQB: VICA), is pleased to announce that its wholly owned UK subsidiary, HCi VioCare Technologies Limited ("HCi VioCare"
has entered into an agreement with the Biomedical Engineering Department of the University of Strathclyde in Glasgow, one of the leading Bioengineering and Prosthetics and Orthotics (P&O) research institutes worldwide, to further the development of its innovative technologies through access to the University's laboratory space and machinery. 
